CompletedNCT05467345
Evaluation of the Performance of CONTOUR NEXT® and CONTOUR PLUS ELITE® BGMS in Neonates Using Capillary Blood Samples
Studying Neonatal diabetes mellitus
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Ascensia Diabetes Care
- Principal Investigator
- Dennis Dietzen, PhDWashington University School of Medicine
- Intervention
- Contour Next and Contour Plus Elite BGMS testing of neonatal blood(device)
- Enrollment
- 120 target
- Eligibility
- All sexes
- Timeline
- 2022 – 2023
Study locations (1)
- St. Louis Children's Hospital, Washington University, St Louis, Missouri, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05467345 on ClinicalTrials.govOther trials for Neonatal diabetes mellitus
Additional recruiting or active studies for the same condition.